Literature DB >> 18472824

Inhibitors of nuclear factor kappa B cause apoptosis in cultured macrophages.

E E Mannick1, J Mishra, J Marque, M Clavell, M J Miller, P D Oliver.   

Abstract

The precise role of the transcription factor nuclear factor kappa B (NF- kappaB) in the regulation of cell survival and cell death is still unresolved and may depend on cell type and position in the cell cycle. The aim of this study was to determine if three pharmacologic inhibitors of NF-kappaB, pyrrolidine dithiocarbamate, N-tosyl-L-lysl chloromethyl ketone and calpain I inhibitor, induce apoptosis in a murine macrophage cell line (RAW 264.7) at doses similar to those required for NF-kappaB inhibition. We found that each of the three inhibitors resulted in a dose- and time-dependent increase in morphologic indices of apoptosis in unstimulated, LPS-stimulated and TNF-stimulated cells. Lethal doses were consistent with those required for NF- kappaB inhibition. We conclude that nuclear NF-kappaB activation may represent an important survival mechanism in macrophages.

Entities:  

Year:  1997        PMID: 18472824      PMCID: PMC2365832          DOI: 10.1080/09629359791721

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  50 in total

1.  Apoptosis: suicide, execution or murder?

Authors:  S J Martin
Journal:  Trends Cell Biol       Date:  1993-05       Impact factor: 20.808

2.  The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.

Authors:  G Franzoso; V Bours; S Park; M Tomita-Yamaguchi; K Kelly; U Siebenlist
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

3.  Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.

Authors:  J Estaquier; M Tanaka; T Suda; S Nagata; P Golstein; J C Ameisen
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

4.  Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis.

Authors:  V Sarma; Z Lin; L Clark; B M Rust; M Tewari; R J Noelle; V M Dixit
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

5.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

6.  Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells.

Authors:  W Zhu; P E Murtha; C Y Young
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575

7.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

8.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Authors:  R I Scheinman; P C Cogswell; A K Lofquist; A S Baldwin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

9.  Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.

Authors:  K Kuwakado; M Kubota; R Bessho; A Kataoka; I Usami; Y W Lin; A Okuda; Y Wakazono
Journal:  Leuk Res       Date:  1995-09       Impact factor: 3.156

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  1 in total

1.  Pharmacologic IKK/NF-κB inhibition causes antigen presenting cells to undergo TNFα dependent ROS-mediated programmed cell death.

Authors:  Jeremy S Tilstra; Daniel F Gaddy; Jing Zhao; Shaival H Davé; Laura J Niedernhofer; Scott E Plevy; Paul D Robbins
Journal:  Sci Rep       Date:  2014-01-10       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.